ClinConnect ClinConnect Logo
Search / Trial NCT06007599

Wound Healing in Primary TKA

Launched by ROTHMAN INSTITUTE ORTHOPAEDICS · Aug 17, 2023

Trial Information

Current as of July 23, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients older than 18 years old that will undergo primary TKA with a midline approach
  • Exclusion Criteria:
  • Previous knee arthroplasty surgeries or midline scars
  • TKA secondary to oncologic or traumatic etiologies
  • BMI ≥ 40
  • uncontrolled diabetes (measured by a Hgb A1c above 8)
  • reported allergy to skin adhesive
  • immunodeficiencies
  • bleeding disorders
  • anticoagulation other than ASA

About Rothman Institute Orthopaedics

Rothman Institute Orthopaedics is a leading healthcare organization specializing in orthopedic care and research. With a commitment to advancing the field of orthopedics, Rothman Institute conducts innovative clinical trials aimed at improving patient outcomes and enhancing treatment methodologies. Renowned for its team of highly skilled orthopedic surgeons and researchers, the institute integrates cutting-edge technology and evidence-based practices to deliver exceptional care. Through its rigorous research initiatives, Rothman Institute is dedicated to fostering advancements in orthopedic medicine and contributing to the overall improvement of musculoskeletal health.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported